tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TOVX Stock Latest News

Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
Press ReleasesTheriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
1M ago
TOVX
Theriva Biologics receives Fast Track Designation for VCN-01
PremiumThe Fly
Theriva Biologics receives Fast Track Designation for VCN-01
1M ago
TOVX
Theriva™ Biologics to Participate in the A.G.P. Virtual Healthcare Conference
PremiumPress Releases
Theriva™ Biologics to Participate in the A.G.P. Virtual Healthcare Conference
2M ago
TOVX
Theriva Biologics Faces Liquidity Crisis: Urgent Capital Needed to Sustain Operations and Clinical Programs
PremiumCompany Announcements
Theriva Biologics Faces Liquidity Crisis: Urgent Capital Needed to Sustain Operations and Clinical Programs
2M ago
TOVX
Theriva Biologics sees cash runway into 1Q25
PremiumThe Fly
Theriva Biologics sees cash runway into 1Q25
2M ago
TOVX
Theriva Biologics reports Q1 EPS (30c) vs. (30c) last year
PremiumThe FlyTheriva Biologics reports Q1 EPS (30c) vs. (30c) last year
2M ago
TOVX
Theriva™ Biologics Reports First Quarter 2024 Operational Highlights and Financial Results
PremiumPress Releases
Theriva™ Biologics Reports First Quarter 2024 Operational Highlights and Financial Results
2M ago
TOVX
Theriva Biologics files $200M mixed securities shelf
PremiumThe Fly
Theriva Biologics files $200M mixed securities shelf
2M ago
TOVX
Theriva Biologics to discuss trial design for VIRAGE
PremiumThe Fly
Theriva Biologics to discuss trial design for VIRAGE
2M ago
TOVX
Theriva™ Biologics to Discuss the Trial Design for VIRAGE – a Phase 2b Clinical Study of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma – at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
Theriva™ Biologics to Discuss the Trial Design for VIRAGE – a Phase 2b Clinical Study of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma – at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
2M ago
TOVX
Theriva Biologics’ VCN-01 Shows Promise in Pediatric Cancer Trial
PremiumCompany Announcements
Theriva Biologics’ VCN-01 Shows Promise in Pediatric Cancer Trial
2M ago
8K
TOVX
Theriva Biologics announces topline data from Phase 1 trial of VCN-01
PremiumThe Fly
Theriva Biologics announces topline data from Phase 1 trial of VCN-01
2M ago
TOVX
Theriva Biologics Reports Breakthrough in Pancreatic Cancer Therapy
PremiumCompany AnnouncementsTheriva Biologics Reports Breakthrough in Pancreatic Cancer Therapy
2M ago
8K
TOVX
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
PremiumPress Releases
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
2M ago
TOVX
Theriva Biologics Upcoming Investor Presentations Insight
PremiumCompany Announcements
Theriva Biologics Upcoming Investor Presentations Insight
3M ago
8K
TOVX
Theriva™ Biologics Reports Full-Year 2023 Operational Highlights and Financial Results
PremiumPress Releases
Theriva™ Biologics Reports Full-Year 2023 Operational Highlights and Financial Results
3M ago
TOVX
Theriva Biologics expects cash to provide runway into 1Q25
PremiumThe Fly
Theriva Biologics expects cash to provide runway into 1Q25
3M ago
TOVX
Theriva Biologics reports 2023 EPS ($1.14) vs. ($1.31) last year
PremiumThe Fly
Theriva Biologics reports 2023 EPS ($1.14) vs. ($1.31) last year
3M ago
TOVX
Theriva™ Biologics to Host Conference Call and Webcast to Discuss Full Year 2023 Operational Highlights and Financial Results
PremiumPress Releases
Theriva™ Biologics to Host Conference Call and Webcast to Discuss Full Year 2023 Operational Highlights and Financial Results
4M ago
TOVX
Theriva™ Biologics to Participate in the BIO-Europe Spring Conference
PremiumPress ReleasesTheriva™ Biologics to Participate in the BIO-Europe Spring Conference
4M ago
TOVX
Theriva Biologics VIRAGE Trial Progresses Positively
PremiumCompany Announcements
Theriva Biologics VIRAGE Trial Progresses Positively
5M ago
8K
TOVX
Theriva Biologics Reports Positive Phase 2b Trial Progress
PremiumCompany Announcements
Theriva Biologics Reports Positive Phase 2b Trial Progress
5M ago
8K
TOVX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >